NHWA: The hydrochloride of Tizanidine tablets has obtained a drug registration certificate
I'm PortAI, I can summarize articles.
According to the Zhitong Finance APP, NHWA announced that the company recently obtained the "Drug Registration Certificate" for the chemical drug Tapentadol Hydrochloride Tablets issued by the National Medical Products Administration. Tapentadol Hydrochloride Tablets are used for the treatment of acute pain in adult patients that is severe enough to require the use of opioid analgesics, as well as for acute pain that cannot be adequately relieved by alternative treatments
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments